Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium catalyzed synthesis offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for high purity pharmaceutical intermediates.
Patent CN111690947B details a metal-free electrochemical method for trifluoromethylation, offering green chemistry solutions and cost reduction in API manufacturing.
Patent CN112225657B reveals a green aqueous Suzuki coupling for Flurbiprofen. Discover cost-effective manufacturing and high-purity supply chain solutions.
Discover a novel method for synthesizing quinolizinone compounds using propiolates and pyridine derivatives. Offers high yields, mild conditions, and cost-effective manufacturing for pharmaceutical intermediates.
Novel iron-catalyzed asymmetric hydrogenation technology using chiral quinoline imidazoline ligands. Reduces noble metal dependency for high-purity pharmaceutical intermediates.
Novel carbonylation cyclization method for N-acyl indoles using solid CO sources. Enhances purity and scalability for pharmaceutical intermediate manufacturing.
Patent CN104662008A reveals novel tetrazole deprotection for Angiotensin II receptor blockers. Achieve cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction in API manufacturing and scalable supply.
Novel room temperature one pot synthesis method for high purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global partners
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering high yields and scalable manufacturing for pharmaceutical applications.
Novel FeCl3-catalyzed route offers high yields and scalability for drug intermediates, reducing costs in API manufacturing.
Patent CN103333144A reveals a high-yield one-pot synthesis for 2-sulfenyl-3-halo benzofurans, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel palladium-catalyzed method enhances purity and scalability for quinolinone compounds, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.
Novel Pd-catalyzed one-pot synthesis for 1,4-diallyl isoquinoline intermediates. Offers high yield, neutral conditions, and scalable manufacturing for pharmaceutical applications.
Novel patent CN114315823B enables safer berberine intermediate production without cyanide. Reduces costs and enhances supply chain reliability for global pharmaceutical manufacturers seeking high purity.
Patent CN1712399B details a novel hybrid synthesis of paclitaxel-MDP conjugates improving solubility and efficacy. Discover cost-effective manufacturing strategies for advanced API intermediates.
Novel Pd-catalyzed carbonylation method for quinazolinones. Enhances purity and reduces toxic gas usage for scalable API manufacturing.
Patent CN112480015A reveals a novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and improved supply chain reliability.
This patent details a cobalt-catalyzed synthesis method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing without precious metals.